The Serum Institute of India has said it will be able to manufacture and supply nine to 10 crore doses doses of Covishield next month, news agency PTI reported on Sunday citing a letter by a senior company official.
Prakash Kumar Singh, the director of government and regulatory affairs at SII, said this in the letter to Union home minister Amit Shah, according to PTI.
Singh’s letter comes as several states have complained about the shortage of jabs and said that they have been forced to shut down over the last few days due to a country-wide shortage.